271 results
Page 4 of 14
424B5
78x23wg3s pyiu
2 Jul 20
Prospectus supplement for primary offering
4:30pm
424B5
yls3sl33b3xo c2ezdl
3 Jun 20
Prospectus supplement for primary offering
10:12am
8-K
EX-99.1
05sxyu2a43fh1ds3
3 Jun 20
ARCA Biopharma announces CLOSING OF $6.1 million registered
9:44am
8-K
EX-99.2
leca2ahc
3 Jun 20
ARCA Biopharma announces CLOSING OF $6.1 million registered
9:44am
8-K
EX-99.1
58tl12zu zb5urbmjcit
1 Jun 20
ARCA Biopharma announces $9.4 million registered
8:27am
8-K
EX-99.1
9rbsx1ljd 6wpvai2fs9
28 May 20
ARCA Biopharma announces AB201 development program for treatment of covid-19 ASSOCIATED COAGulopAthy
5:15pm
8-K
EX-99.1
d63efb4
6 May 20
ARCA Biopharma announces First quarter 2020 financial results AND Provides CorporatE update
4:40pm
8-K
EX-99.1
ruq qpom84yl37
18 Feb 20
ARCA Biopharma announces FISCAL YEAR 2019 financial results AND Provides CorporatE update
4:36pm
8-K
EX-99.2
i880n1d 422
18 Feb 20
ARCA Biopharma announces FISCAL YEAR 2019 financial results AND Provides CorporatE update
4:36pm
8-K
EX-99.1
r1o4 l3r3g7
6 Nov 19
ARCA Biopharma announces third quarter 2019 financial results AND Provides CorporatE update
4:15pm
8-K
EX-99.2
cl0v66h8ou86z5 56
6 Nov 19
ARCA Biopharma announces third quarter 2019 financial results AND Provides CorporatE update
4:15pm
8-K
EX-99.1
e8fh5quzmk398x
1 Aug 19
ARCA Biopharma announces second quarter 2019 financial results AND Provides CorporatE update
4:46pm